Bias due to isotopic incorporation in both relative and absolute protein quantitation with carbon-13 and nitrogen-15 labeled peptides

IF 2.1 Q4 Chemistry Clinical Mass Spectrometry Pub Date : 2017-01-01 DOI:10.1016/j.clinms.2017.04.002
Brian A. Rappold, Andrew N. Hoofnagle
{"title":"Bias due to isotopic incorporation in both relative and absolute protein quantitation with carbon-13 and nitrogen-15 labeled peptides","authors":"Brian A. Rappold,&nbsp;Andrew N. Hoofnagle","doi":"10.1016/j.clinms.2017.04.002","DOIUrl":null,"url":null,"abstract":"<div><p>Mass spectrometry provides considerable benefits over other analytical techniques due to advantages imparted by the use of isotopically labeled internal standards. In some analytical approaches, the internal standard provides reference points for quantitative data reduction. However, there is an important phenomenon that occurs in the development of an internal standard, namely the distribution of naturally occurring isotopes is altered by artificial labeling. As a result, the number of molecules measured in each isotopic state (e.g., +0, +1, +2) varies between the manufactured internal standard and the naturally occurring unmodified analyte. This can create inaccuracies that are a function of the abundance, type and location of the isotopic labeling when internal standards act as the calibration material. In this study, theoretical examples calculated with naturally occurring isotopic incorporation, manufactured isotopic enrichment, and experimental data from comparative analysis of naturally and artificially labeled peptides were explored to demonstrate the variation in measurement between analytes and their stable, isotopically labeled internal standards.</p></div>","PeriodicalId":48565,"journal":{"name":"Clinical Mass Spectrometry","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.clinms.2017.04.002","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Mass Spectrometry","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2376999816300216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Chemistry","Score":null,"Total":0}
引用次数: 4

Abstract

Mass spectrometry provides considerable benefits over other analytical techniques due to advantages imparted by the use of isotopically labeled internal standards. In some analytical approaches, the internal standard provides reference points for quantitative data reduction. However, there is an important phenomenon that occurs in the development of an internal standard, namely the distribution of naturally occurring isotopes is altered by artificial labeling. As a result, the number of molecules measured in each isotopic state (e.g., +0, +1, +2) varies between the manufactured internal standard and the naturally occurring unmodified analyte. This can create inaccuracies that are a function of the abundance, type and location of the isotopic labeling when internal standards act as the calibration material. In this study, theoretical examples calculated with naturally occurring isotopic incorporation, manufactured isotopic enrichment, and experimental data from comparative analysis of naturally and artificially labeled peptides were explored to demonstrate the variation in measurement between analytes and their stable, isotopically labeled internal standards.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
碳-13和氮-15标记肽在相对和绝对蛋白质定量中由于同位素掺入而产生的偏差
由于使用同位素标记的内标物所带来的优势,质谱法比其他分析技术具有相当大的优势。在一些分析方法中,内部标准为定量数据简化提供参考点。然而,在制定内部标准的过程中出现了一个重要的现象,即自然存在的同位素的分布被人为标记所改变。因此,在每个同位素状态(例如,+0,+1,+2)下测量的分子数在制造的内标准物和自然存在的未修饰分析物之间变化。当内部标准作为校准材料时,这可能会产生不准确性,这是同位素标记的丰度,类型和位置的函数。在本研究中,利用自然同位素掺入、人工同位素富集计算的理论算例,以及自然和人工标记多肽的对比分析实验数据进行了探讨,以证明分析物与其稳定的、同位素标记的内标之间的测量差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Mass Spectrometry
Clinical Mass Spectrometry Chemistry-Spectroscopy
CiteScore
1.70
自引率
0.00%
发文量
0
期刊介绍: Clinical Mass Spectrometry publishes peer-reviewed articles addressing the application of mass spectrometric technologies in Laboratory Medicine and Clinical Pathology with the focus on diagnostic applications. It is the first journal dedicated specifically to the application of mass spectrometry and related techniques in the context of diagnostic procedures in medicine. The journal has an interdisciplinary approach aiming to link clinical, biochemical and technological issues and results.
期刊最新文献
Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation A proposal for score assignment to characterize biological processes from mass spectral analysis of serum Analysis of urinary VOCs using mass spectrometric methods to diagnose cancer: A review Analysis of 17 fentanyls in plasma and blood by UPLC-MS/MS with interpretation of findings in surgical and postmortem casework Collision energy-breakdown curves – An additional tool to characterize MS/MS methods
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1